Form D — Nok Therapeutics, Inc.
0001213900-26-046533 · filed Apr 22, 2026
Offering amounts describe securities offered; amounts sold are issuer-reported as of each filing. Amendments can repeat earlier amounts. We do not add these figures into a capital-raised total. Missing amounts are not zero. Data coverage and methodology · How to interpret the amounts.
Check this disclosure on SEC EDGAR · More Biotechnology filings
Offering
- Industry
- Biotechnology
- Exemptions
- 06b
- Reported offering amount
- —
- Reported amount sold
- $500,500
- Minimum investment
- $0
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- Nok Therapeutics, Inc.
- CIK
- 2038166
- Entity
- Corporation
- Jurisdiction
- FLORIDA
- Year incorporated
- 2024
- Address
- 2009 MACKENZIE WAY
CRANBERRY TWP., PA 16066 - Phone
- 888-691-5839
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
Robert Lewis · Executive OfficerMadison, MS Find on LinkedIn ↗
-
Brian Cogley · Executive OfficerCranberry Twp, PA Find on LinkedIn ↗
-
Bruce Cassidy · DirectorSarasota, FL Find on LinkedIn ↗
-
Martin Lewis · DirectorPlainview, TX Find on LinkedIn ↗
-
Michael Lewis · PromoterFort Myers, FL Find on LinkedIn ↗
-
David Mehalick · PromoterNaples, FL Find on LinkedIn ↗
Other filings from this issuer
- Form D — May 1, 2026 — 0001213900-26-050987
- Form D — May 1, 2026 — 0001213900-26-050994
- Form D — Apr 22, 2026 — 0001213900-26-046528
- Form D — Apr 22, 2026 — 0001213900-26-046538
- Form D — Mar 26, 2026 — 0001213900-26-034315
- Form D — Oct 24, 2025 — 0001213900-25-102039
- Form D — Oct 24, 2025 — 0001213900-25-102036
View the original filing on SEC EDGAR ↗